VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Lorazepam Mylan
Approved
Small molecule
U
Universitaire Ziekenhuizen KU Leuven
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Sedation
1 trial
Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability
Active, not recruiting
·
U
Universitaire Ziekenhuizen KU Leuven
·
Phase 4
·
NCT02078336
·
40 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Lorazepam Mylan. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Lorazepam Mylan compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Lorazepam Mylan. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Universitaire Ziekenhuizen KU Leuven company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Approved
[1]
Company
U
Universitaire Ziekenhuizen KU Leuven
Related News